Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis

International Journal of Molecular Sciences

Volumn 14, Issue 5, 2013, Pages 10015-10041

  Wang, Jun ^a   Guo, Yan ^b   Chu, Huili ^a   Guan, Yaping ^a   Bi, Jingwang ^a   Wang, Baocheng ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b Military Command of Shandong Province ^*  (China)

Author keywords

HuR; MRNA stability; Prognosis; Progression

Indexed keywords

ARSENIC TRIOXIDE; CISPLATIN; CYCLOOXYGENASE 2; DOXORUBICIN; GELATINASE B; GEMCITABINE; HUR PROTEIN; MICRORNA; PACLITAXEL; TAMOXIFEN; ELAV LIKE PROTEIN 1; MESSENGER RNA;

AUTOREGULATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STAGING; CARCINOGENESIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOPLASM; DISEASE FREE SURVIVAL; EVENT FREE SURVIVAL; GENE EXPRESSION REGULATION; HUMAN; LIVER CELL CARCINOMA; METASTASIS; METASTASIS FREE SURVIVAL; NONHUMAN; OVERALL SURVIVAL; PANCREAS CARCINOMA; PRECANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; REVIEW; SOLID TUMOR; TREATMENT RESPONSE; TRIPLE NEGATIVE BREAST CANCER; TUMOR INVASION; TUMOR VASCULARIZATION; UBIQUITINATION; ANIMAL; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY; PROGNOSIS; PROTEIN TRANSPORT;

ANIMALS; ELAV-LIKE PROTEIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PROGNOSIS; PROTEIN TRANSPORT; RNA, MESSENGER;

EID: 84877821108     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140510015     Document Type: Review

References (176)

1. Campos, A.R.; Grossman, D.; White, K. Mutant alleles at the locus elav in Drosophila melanogaster lead to nervous system defects. A developmental-genetic analysis. J. Neurogenet. 1985, 2, 197-218.
2. Ma, W.J.; Cheng, S.; Campbell, C.; Wright, A.; Furneaux, H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 1996, 271, 8144-8151.
3. Ma, W.J.; Furneaux, H. Localization of the human HuR gene to chromosome 19p13.2. Hum. Genet. 1997, 99, 32-33.
4. Robinow, S.; Campos, A.R.; Yao, K.M.; White, K. The elav gene product of Drosophila, required in neurons, has three RNP consensus motifs. Science 1988, 242, 1570-1572.
5. Dalmau, J.; Furneaux, H.M.; Cordon-Cardo, C.; Posner, J.B. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am. J. Pathol. 1992, 141, 881-886.
6. King, P.H.; Dropcho, E.J. Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma. Ann. Neurol. 1996, 39, 679-681.
7. King, P.H. Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: Evidence for down-regulation of HuD in the variant phenotype. Int. J. Cancer 1997, 74, 378-382.
8. Srikantan, S.; Gorospe, M. HuR function in disease. Front. Biosci. 2012, 17, 189-205.
9. Von Roretz, C.; di Marco, S.; Mazroui, R.; Gallouzi, I.E. Turnover of AU-rich-containing mRNAs during stress: A matter of survival. Wiley Interdiscip. Rev. RNA 2011, 2, 336-347.
10. Abdelmohsen, K.; Gorospe, M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip. Rev. RNA 2010, 1, 214-229.
11. Xiao, L.; Wang, J.Y. Posttranscriptional regulation of gene expression in epithelial cells by polyamines. Methods Mol. Biol. 2011, 720, 67-79.
12. Carpenter, B.; MacKay, C.; Alnabulsi, A.; MacKay, M.; Telfer, C.; Melvin, W.T.; Murray, G.I. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim. Biophys. Acta 2006, 1765, 85-100.
13. Zhou, Z.J.; Dai, Z.; Zhou, S.L.; Fu, X.T.; Zhao, Y.M.; Shi, Y.H.; Zhou, J.; Fan, J. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma. Int. J. Cancer 2013, 132, 1080-1089.
14. Wu, S.; Sato, M.; Endo, C.; Sakurada, A.; Dong, B.; Aikawa, H.; Chen, Y.; Okada, Y.; Matsumura, Y.; Sueoka, E.; et al. hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. Lung Cancer 2003, 41, 179-186.
15. Hope, N.R.; Murray, G.I. The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: Relationship of heterogeneous nuclear ribonucleoproteins with prognosis. Hum. Pathol. 2011, 42, 393-402.
16. Carpenter, B.; McKay, M.; Dundas, S.R.; Lawrie, L.C.; Telfer, C.; Murray, G.I. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br. J. Cancer 2006, 95, 921-927.
17. Papadopoulou, C.; Ganou, V.; Patrinou-Georgoula, M.; Guialis, A. HuR-hnRNP interactions and the effect of cellular stress. Mol. Cell Biochem. 2013, 372, 137-147.
18. Srikantan, S.; Tominaga, K.; Gorospe, M. Functional interplay between RNA-binding protein HuR and microRNAs. Curr. Protein Pept. Sci. 2012, 13, 372-379.
19. Bhattacharyya, S.N.; Habermacher, R.; Martine, U.; Closs, E.I.; Filipowicz, W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125, 1111-1124.
20. Srikantan, S.; Abdelmohsen, K.; Lee, E.K.; Tominaga, K.; Subaran, S.S.; Kuwano, Y.; Kulshrestha, R.; Panchakshari, R.; Kim, H.H.; Yang, X.; et al. Translational control of TOP2A influences doxorubicin efficacy. Mol. Cell Biol. 2011, 31, 3790-3801.
21. Tominaga, K.; Srikantan, S.; Lee, E.K.; Subaran, S.S.; Martindale, J.L.; Abdelmohsen, K.; Gorospe, M. Competitive regulation of nucleolin expression by HuR and miR-494. Mol. Cell Biol. 2011, 31, 4219-4231.
22. Wang, W.; Caldwell, M.C.; Lin, S.; Furneaux, H.; Gorospe, M. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J. 2000, 19, 2340-2350.
23. Epis, M.R.; Barker, A.; Giles, K.M.; Beveridge, D.J.; Leedman, P.J. The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells. J. Biol. Chem. 2011, 286, 41442-41454.
24. Kim, H.H.; Kuwano, Y.; Srikantan, S.; Lee, E.K.; Martindale, J.L.; Gorospe, M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev. 2009, 23, 1743-1748.
25. Glorian, V.; Maillot, G.; Poles, S.; Iacovoni, J.S.; Favre, G.; Vagner, S. HuR-dependent loading of miRNA RISC to the mRNA encoding the Ras-related small GTPase RhoB controls its translation during UV-induced apoptosis. Cell Death Differ. 2011, 18, 1692-1701.
26. Chang, N.; Yi, J.; Guo, G.; Liu, X.; Shang, Y.; Tong, T.; Cui, Q.; Zhan, M.; Gorospe, M.; Wang, W. HuR uses AUF1 as a cofactor to promote p16INK4 mRNA decay. Mol. Cell Biol. 2010, 30, 3875-3886.
27. Li, B.; Si, J.; DeWille, J.W. Ultraviolet radiation (UVR) activates p38 MAP kinase and induces post-transcriptional stabilization of the C/EBPdelta mRNA in G0 growth arrested mammary epithelial cells. J. Cell Biochem. 2008, 103, 1657-1669.
28. Wang, W.; Furneaux, H.; Cheng, H.; Caldwell, M.C.; Hutter, D.; Liu, Y.; Holbrook, N.; Gorospe, M. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell Biol. 2000, 20, 760-769.
29. Nagy, L.E. Stabilization of tumor necrosis factor-alpha mRNA in macrophages in response to chronic ethanol exposure. Alcohol 2004, 33, 229-233.
30. McMullen, M.R.; Cocuzzi, E.; Hatzoglou, M.; Nagy, L.E. Chronic ethanol exposure increases the binding of HuR to the TNFalpha 3'-untranslated region in macrophages. J. Biol. Chem. 2003, 278, 38333-38341.
31. Lin, W.N.; Lin, C.C.; Cheng, H.Y.; Yang, C.M. Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: Involvement of NADPH oxidase reactive oxygen species and mitogen-activated protein kinases. Br. J. Pharmacol. 2011, 163, 1691-1706.
32. Lin, F.Y.; Chen, Y.H.; Lin, Y.W.; Tsai, J.S.; Chen, J.W.; Wang, H.J.; Chen, Y.L.; Li, C.Y.; Lin, S.J. The role of human antigen R: An RNA-binding protein; in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin. a novel mechanism involved in vascular inflammation. Arterioscler Thromb Vasc. Biol. 2006, 26, 2622-2629.
33. Hostetter, C.; Licata, L.A.; Witkiewicz, A.; Costantino, C.L.; Yeo, C.J.; Brody, J.R.; Keen, J.C. Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells. Cancer Biol. Ther. 2008, 7, 1496-1506.
34. Costantino, C.L.; Witkiewicz, A.K.; Kuwano, Y.; Cozzitorto, J.A.; Kennedy, E.P.; Dasgupta, A.; Keen, J.C.; Yeo, C.J.; Gorospe, M.; Brody, J.R. The role of HuR in gemcitabine efficacy in pancreatic cancer. HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. Cancer Res. 2009, 69, 4567-4572.
35. Chen, L.; Jarujaron, S.; Wu, X.; Sun, L.; Zha, W.; Liang, G.; Wang, X.; Gurley, E.C.; Studer, E.J.; Hylemon, P.B.; et al. HIV protease inhibitor lopinavir-induced TNF-alpha and IL-6 expression is coupled to the unfolded protein response and ERK signaling pathways in macrophages. Biochem. Pharmacol. 2009, 78, 70-77.
36. Bonelli, M.A.; Alfieri, R.R.; Desenzani, S.; Petronini, P.G.; Borghetti, A.F. Proteasome inhibition increases HuR level, restores heat-inducible HSP72 expression and thermotolerance in WI-38 senescent human fibroblasts. Exp. Gerontol. 2004, 39, 423-432.
37. Levy, N.S.; Chung, S.; Furneaux, H.; Levy, A.P. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 1998, 273, 6417-6423.
38. Yaman, I.; Fernandez, J.; Sarkar, B.; Schneider, R.J.; Snider, M.D.; Nagy, L.E.; Hatzoglou, M. Nutritional control of mRNA stability is mediated by a conserved AU-rich element that binds the cytoplasmic shuttling protein HuR. J. Biol. Chem. 2002, 277, 41539-41546.
39. Perrone, E.E.; Liu, L.; Turner, D.J.; Strauch, E.D. Bile salts increase epithelial cell proliferation through HuR-induced c-Myc expression. J. Surg. Res. 2012, 178, 155-161.
40. Atasoy, U.; Watson, J.; Patel, D.; Keene, J.D. ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J. Cell Sci. 1998, 111, 3145-3156.
41. Zou, T.; Rao, J.N.; Liu, L.; Xiao, L.; Yu, T.X.; Jiang, P.; Gorospe, M.; Wang, J.Y. Polyamines regulate the stability of JunD mRNA by modulating the competitive binding of its 3' untranslated region to HuR and AUF1. Mol. Cell Biol. 2010, 30, 5021-5032.
42. Zou, T.; Liu, L.; Rao, J.N.; Marasa, B.S.; Chen, J.; Xiao, L.; Zhou, H.; Gorospe, M.; Wang, J.Y. Polyamines modulate the subcellular localization of RNA-binding protein HuR through AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha1. Biochem. J. 2008, 409, 389-398.
43. Zou, T.; Mazan-Mamczarz, K.; Rao, J.N.; Liu, L.; Marasa, B.S.; Zhang, A.H.; Xiao, L.; Pullmann, R.; Gorospe, M.; Wang, J.Y. Polyamine depletion increases cytoplasmic levels of RNA-binding protein HuR leading to stabilization of nucleophosmin and p53 mRNAs. J. Biol. Chem. 2006, 281, 19387-19394.
44. Serini, S.; Fasano, E.; Piccioni, E.; Monego, G.; Cittadini, A.R.; Celleno, L.; Ranelletti, F.O.; Calviello, G. DHA induces apoptosis and differentiation in human melanoma cells in vitro. involvement of HuR-mediated COX-2 mRNA stabilization and beta-catenin nuclear translocation. Carcinogenesis 2012, 33, 164-173.
45. Cao, H.; Kelly, M.A.; Kari, F.; Dawson, H.D.; Urban, J.F., Jr.; Coves, S.; Roussel, A.M.; Anderson, R.A. Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. J. Inflamm. 2007, 4, doi:10.1186/1476-9255-4-1.
46. Zhang, J.; Ouyang, W.; Li, J.; Zhang, D.; Yu, Y.; Wang, Y.; Li, X.; Huang, C. Suberoylanilide hydroxamic acid (SAHA) inhibits EGF-induced cell transformation via reduction of cyclin D1 mRNA stability. Toxicol. Appl. Pharmacol. 2012, 263, 218-224.
47. Hwang, Y.S.; Park, K.K.; Chung, W.Y. Kalopanaxsaponin A inhibits the invasion of human oral squamous cell carcinoma by reducing metalloproteinase-9 mRNA stability and protein trafficking. Biol. Pharm. Bull. 2012, 35, 289-300.
48. Sun, L.; Zhang, S.; Jiang, Z.; Huang, X.; Wang, T.; Li, H.; Zhang, L. Triptolide inhibits COX-2 expression by regulating mRNA stability in TNF-alpha-treated A549 cells. Biochem. Biophys. Res. Commun. 2011, 416, 99-105.
49. Suswam, E.A.; Nabors, L.B.; Huang, Y.; Yang, X.; King, P.H. IL-1beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3' untranslated region. Involvement of divergent RNA-binding factors HuR, KSRP and TIAR. Int. J. Cancer 2005, 113, 911-919.
50. Nabors, L.B.; Suswam, E.; Huang, Y.; Yang, X.; Johnson, M.J.; King, P.H. Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells. A role for RNA stabilization and HuR. Cancer Res. 2003, 63, 4181-4187.
51. Chae, K.S.; Kang, M.J.; Lee, J.H.; Ryu, B.K.; Lee, M.G.; Her, N.G.; Ha, T.K.; Han, J.; Kim, Y.K.; Chi, S.G. Opposite functions of HIF-alpha isoforms in VEGF induction by TGF-beta1 under non-hypoxic conditions. Oncogene 2011, 30, 1213-1228.
52. Cho, N.H.; Kang, S.; Hong, S.; An, H.J.; Choi, Y.H.; Jeong, G.B.; Choi, H.K. Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection. Cancer Lett. 2006, 232, 170-178.
53. Cumming, S.A.; Chuen-Im, T.; Zhang, J.; Graham, S.V. The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells. Virology 2009, 383, 142-149.
54. Dickson, A.M.; Anderson, J.R.; Barnhart, M.D.; Sokoloski, K.J.; Oko, L.; Opyrchal, M.; Galanis, E.; Wilusz, C.J.; Morrison, T.E.; Wilusz, J. Dephosphorylation of HuR Protein during alphavirus infection is associated with HuR relocalization to the cytoplasm. J. Biol. Chem. 2012, 287, 36229-36238.
55. Cherradi, N.; Lejczak, C.; Desroches-Castan, A.; Feige, J.J. Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin. Mol. Endocrinol. 2006, 20, 916-930.
56. Sheflin, L.G.; Zou, A.P.; Spaulding, S.W. Androgens regulate the binding of endogenous HuR to the AU-rich 3'UTRs of HIF-1alpha and EGF mRNA. Biochem. Biophys. Res. Commun. 2004, 322, 644-651.
57. Sheflin, L.G.; Zhang, W.; Spaulding, S.W. Androgen regulates the level and subcellular distribution of the AU-rich ribonucleic acid-binding protein HuR both in vitro and in vivo. Endocrinology 2001, 142, 2361-2368.
58. Karipcin, F.S.; Ensari, T.A.; Kayisli, U.A.; Guzel, E.; Kallen, C.B.; Seli, E. The mRNA-binding protein HuR is regulated in the menstrual cycle and repressed in ectopic endometrium. Reprod. Sci. 2011, 18, 145-155.
59. Guttinger, S.; Muhlhausser, P.; Koller-Eichhorn, R.; Brennecke, J.; Kutay, U. Transportin2 functions as importin and mediates nuclear import of HuR. Proc. Natl. Acad. Sci. USA 2004, 101, 2918-2923.
60. Fan, X.C.; Steitz, J.A. HNS: A nuclear-cytoplasmic shuttling sequence in HuR. Proc. Natl. Acad. Sci. USA 1998, 95, 15293-15298.
61. Doller, A.; Huwiler, A.; Muller, R.; Radeke, H.H.; Pfeilschifter, J.; Eberhardt, W. Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR. implications for posttranscriptional regulation of cyclooxygenase-2. Mol. Biol. Cell 2007, 18, 2137-2148.
62. Doller, A.; Akool, el-S.; Huwiler, A.; Muller, R.; Radeke, H.H.; Pfeilschifter, J.; Eberhardt, W. Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol. Cell Biol. 2008, 28, 2608-2625.
63. Kim, H.H.; Abdelmohsen, K.; Lal, A.; Pullmann, R., Jr.; Yang, X.; Galban, S.; Srikantan, S.; Martindale, J.L.; Blethrow, J.; Shokat, K.M.; et al. Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev. 2008, 22, 1804-1815.
64. Abdelmohsen, K.; Pullmann, R., Jr.; Lal, A.; Kim, H.H.; Galban, S.; Yang, X.; Blethrow, J.D.; Walker, M.; Shubert, J.; Gillespie, D.A.; et al. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell 2007, 25, 543-557.
65. Lafarga, V.; Cuadrado, A.; Lopez de Silanes, I.; Bengoechea, R.; Fernandez-Capetillo, O.; Nebreda, A.R. p38 Mitogen-activated protein kinase-and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol. Cell Biol. 2009, 29, 4341-4351.
66. Li, H.; Park, S.; Kilburn, B.; Jelinek, M.A.; Henschen-Edman, A.; Aswad, D.W.; Stallcup, M.R.; Laird-Offringa, I.A. Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase. J. Biol. Chem. 2002, 277, 44623-44630.
67. Abdelmohsen, K.; Srikantan, S.; Yang, X.; Lal, A.; Kim, H.H.; Kuwano, Y.; Galban, S.; Becker, K.G.; Kamara, D.; de Cabo, R.; et al. Ubiquitin-mediated proteolysis of HuR by heat shock. EMBO J. 2009, 28, 1271-1282.
68. Wang, W.; Yang, X.; Kawai, T.; Lopez de Silanes, I.; Mazan-Mamczarz, K.; Chen, P.; Chook, Y.M.; Quensel, C.; Kohler, M.; Gorospe, M. AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha1. Involvement in the nuclear import of RNA-binding protein HuR. J. Biol. Chem. 2004, 279, 48376-48388.
69. Wang, W.; Yang, X.; Lopez de Silanes, I.; Carling, D.; Gorospe, M. Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J. Biol. Chem. 2003, 278, 27016-27023.
70. Annabi, B.; Currie, J.C.; Moghrabi, A.; Beliveau, R. Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg. Leuk. Res. 2007, 31, 1277-1284.
71. Lin, F.Y.; Chen, Y.H.; Chen, Y.L.; Wu, T.C.; Li, C.Y.; Chen, J.W.; Lin, S.J. Ginkgo biloba extract inhibits endotoxin-induced human aortic smooth muscle cell proliferation via suppression of toll-like receptor 4 expression and NADPH oxidase activation. J. Agric. Food Chem. 2007, 55, 1977-1984.
72. Kang, M.J.; Ryu, B.K.; Lee, M.G.; Han, J.; Lee, J.H.; Ha, T.K.; Byun, D.S.; Chae, K.S.; Lee, B.H.; Chun, H.S.; et al. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis. Gastroenterology 2008, 135, 2030-2042.
73. Jeyaraj, S.C.; Singh, M.; Ayupova, D.A.; Govindaraju, S.; Lee, B.S. Transcriptional control of human antigen R by bone morphogenetic protein. J. Biol. Chem. 2010, 285, 4432-4440.
74. Al-Ahmadi, W.; Al-Ghamdi, M.; Al-Souhibani, N.; Khabar, K.S. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. J. Pathol. 2013, 230, 28-38.
75. Prislei, S.; Martinelli, E.; Mariani, M.; Raspaglio, G.; Sieber, S.; Ferrandina, G.; Shahabi, S.; Scambia, G.; Ferlini, C. MiR-200c and HuR in ovarian cancer. BMC Cancer 2013, 13, 72.
76. Leucci, E.; Zriwil, A.; Gregersen, L.H.; Jensen, K.T.; Obad, S.; Bellan, C.; Leoncini, L.; Kauppinen, S.; Lund, A.H. Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene 2012, 31, 5081-5089.
77. Kojima, K.; Fujita, Y.; Nozawa, Y.; Deguchi, T.; Ito, M. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms. Prostate 2010, 70, 1501-1512.
78. Xu, F.; Zhang, X.; Lei, Y.; Liu, X.; Liu, Z.; Tong, T.; Wang, W. Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma. J. Cell Biochem. 2010, 111, 727-734.
79. Guo, X.; Wu, Y.; Hartley, R.S. MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol. 2009, 6, 575-583.
80. Marasa, B.S.; Srikantan, S.; Martindale, J.L.; Kim, M.M.; Lee, E.K.; Gorospe, M.; Abdelmohsen, K. MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence. Aging 2010, 2, 333-343.
81. Abdelmohsen, K.; Srikantan, S.; Kuwano, Y.; Gorospe, M. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc. Natl. Acad. Sci. USA 2008, 105, 20297-20302.
82. Abdelmohsen, K.; Kim, M.M.; Srikantan, S.; Mercken, E.M.; Brennan, S.E.; Wilson, G.M.; Cabo, R.; Gorospe, M. miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 2010, 9, 1354-1359.
83. Dai, W.; Zhang, G.; Makeyev, E.V. RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usage. Nucleic Acids Res. 2012, 40, 787-800.
84. Mansfield, K.D.; Keene, J.D. Neuron-specific ELAV/Hu proteins suppress HuR mRNA during neuronal differentiation by alternative polyadenylation. Nucleic Acids Res. 2012, 40, 2734-2746.
85. Williams, T.K.; Costantino, C.L.; Bildzukewicz, N.A.; Richards, N.G.; Rittenhouse, D.W.; Einstein, L.; Cozzitorto, J.A.; Keen, J.C.; Dasgupta, A.; Gorospe, M.; et al. pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs. PLoS One 2010, 5, e15455.
86. Cho, S.J.; Zhang, J.; Chen, X. RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability. Nucleic Acids Res. 2010, 38, 2256-2267.
87. Cho, S.J.; Jung, Y.S.; Zhang, J.; Chen, X. The RNA-binding protein RNPC1 stabilizes the mRNA encoding the RNA-binding protein HuR and cooperates with HuR to suppress cell proliferation. J. Biol. Chem. 2012, 287, 14535-14544.
88. Embade, N.; Fernández-Ramos, D.; Varela-Rey, M.; Beraza, N.; Sini, M.; Gutiérrez de Juan, V.; Woodhoo, A.; Martínez-López, N.; Rodríguez-Iruretagoyena, B.; Bustamante, F.J.; et al. Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation. Hepatology 2012, 55, 1237-1248.
89. Gabai, V.L.; Meng, L.; Kim, G.; Mills, T.A.; Benjamin, I.J.; Sherman, M.Y. Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR. Mol. Cell Biol. 2012, 32, 929-940.
90. Al-Ahmadi, W.; Al-Ghamdi, M.; Al-Haj, L.; Al-Saif, M.; Khabar, K.S. Alternative polyadenylation variants of the RNA binding protein.; HuR. Abundance, role of AU-rich elements and auto-Regulation. Nucleic Acids Res. 2009, 37, 3612-3624.
91. Talwar, S.; Jin, J.; Carroll, B.; Liu, A.; Gillespie, M.B.; Palanisamy, V. Caspase-mediated cleavage of RNA-binding protein HuR regulates c-Myc protein expression after hypoxic stress. J. Biol. Chem. 2011, 286, 32333-32343.
92. Yi, J.; Chang, N.; Liu, X.; Guo, G.; Xue, L.; Tong, T.; Gorospe, M.; Wang, W. Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence. Nucleic Acids Res. 2010, 38, 1547-1558.
93. Upadhyay, R.; Sanduja, S.; Kaza, V.; Dixon, D.A. Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival. Int. J. Cancer 2012, 132, E128-E138.
94. Cleary, M.L.; Mellentin, J.D.; Spies, J.; Smith, S.D. Chromosomal translocation involving the beta T cell receptor gene in acute leukemia. J. Exp. Med. 1998, 167, 682-687.
95. Bitoun, M.; Maugenre, S.; Jeannet, P.Y.; Lacène, E.; Ferrer, X.; Laforêt, P.; Martin, J.J.; Laporte, J.; Lochmüller, H.; Beggs, A.H.; et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat. Genet. 2005, 37, 1207-1209.
96. Rosette, C.; Roth, R.B.; Oeth, P.; Braun, A.; Kammerer, S.; Ekblom, J.; Denissenko, M.F. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 2005, 26, 943-950.
97. Koljonen, V.; Bohling, T.; Haglund, C.; Ristimaki, A. Expression of HuR in Merkel cell carcinoma and in normal skin. J. Cutan Pathol. 2008, 35, 10-14.
98. Kim, K.Y.; Li, S.; Cha, J.D.; Zhang, X.; Cha, I.H. Significance of molecular markers in survival prediction of oral squamous cell carcinoma. Head Neck. 2012, 34, 929-936.
99. Denkert, C.; Koch, I.; von Keyserlingk, N.; Noske, A.; Niesporek, S.; Dietel, M.; Weichert, W. Expression of the ELAV-like protein HuR in human colon cancer. Association with tumor stage and cyclooxygenase-2. Mod Pathol. 2006, 19, 1261-1269.
100. Mrena, J.; Wiksten, J.P.; Thiel, A.; Kokkola, A.; Pohjola, L.; Lundin, J.; Nordling, S.; Ristimaki, A.; Haglund, C. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR. Clin. Cancer Res. 2005, 11, 7362-7368.
101. Wang, J.; Zhao, W.; Guo, Y.; Zhang, B.; Xie, Q.; Xiang, D.; Gao, J.; Wang, B.; Chen, Z. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis. Oncology 2009, 76, 420-429.
102. Wang, J.; Wang, B.; Bi, J.; Zhang, C. Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer. Med. Oncol. 2011, 28, S577-S585.
103. Denkert, C.; Weichert, W.; Winzer, K.J.; Muller, B.M.; Noske, A.; Niesporek, S.; Kristiansen, G.; Guski, H.; Dietel, M.; Hauptmann, S. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin. Cancer Res. 2004, 10, 5580-5586.
104. Denkert, C.; Weichert, W.; Pest, S.; Koch, I.; Licht, D.; Kobel, M.; Reles, A.; Sehouli, J.; Dietel, M.; Hauptmann, S. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res. 2004, 64, 189-195.
105. Danilin, S.; Sourbier, C.; Thomas, L.; Lindner, V.; Rothhut, S.; Dormoy, V.; Helwig, J.J.; Jacqmin, D.; Lang, H.; Massfelder, T. Role of the RNA-binding protein HuR in human renal cell carcinoma. Carcinogenesis 2010, 31, 1018-1026.
106. Kim, G.Y.; Lim, S.J.; Kim, Y.W. Expression of HuR, COX-2, and survivin in lung cancers, cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas. Mod Pathol. 2011, 24, 1336-1347.
107. Mrena, J.; Wiksten, J.P.; Kokkola, A.; Nordling, S.; Ristimaki, A.; Haglund, C. COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer. Tumour Biol. 2010, 31, 1-7.
108. Stoppoloni, D.; Cardillo, I.; Verdina, A.; Vincenzi, B.; Menegozzo, S.; Santini, M.; Sacchi, A.; Baldi, A.; Galati, R. Expression of the embryonic lethal abnormal vision-like protein HuR in human mesothelioma: Association with cyclooxygenase-2 and prognosis. Cancer 2008, 113, 2761-2769.
109. Miyata, Y.; Watanabe, S.; Sagara, Y.; Mitsunari, K.; Matsuo, T.; Ohba, K.; Sakai, H. High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer. PLoS One 2013, 8, e59095.
110. Heinonen, M.; Fagerholm, R.; Aaltonen, K.; Kilpivaara, O.; Aittomaki, K.; Blomqvist, C.; Heikkila, P.; Haglund, C.; Nevanlinna, H.; Ristimaki, A. Prognostic role of HuR in hereditary breast cancer. Clin. Cancer Res. 2007, 13, 6959-6963.
111. Heinonen, M.; Bono, P.; Narko, K.; Chang, S.H.; Lundin, J.; Joensuu, H.; Furneaux, H.; Hla, T.; Haglund, C.; Ristimaki, A. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res. 2005, 65, 2157-2161.
112. Lim, S.J.; Kim, H.J.; Kim, J.Y.; Park, K.; Lee, C.M. Expression of HuR is associated with increased cyclooxygenase-2 expression in uterine cervical carcinoma. Int. J. Gynecol. Pathol. 2007, 26, 229-234.
113. Blaxall, B.C.; Dwyer-Nield, L.D.; Bauer, A.K.; Bohlmeyer, T.J.; Malkinson, A.M.; Port, J.D. Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol. Carcinog. 2000, 28, 76-83.
114. Barbisan, F.; Mazzucchelli, R.; Santinelli, A.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M.; Montorsi, F.; Montironi, R. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies. Eur. Urol. 2009, 56, 105-112.
115. Brosens, L.A.; Keller, J.J.; Pohjola, L.; Haglund, C.; Morsink, F.H.; Iacobuzio-Donahue, C.; Goggins, M.; Giardiello, F.M.; Ristimaki, A.; Offerhaus, G.J. Increased expression of cytoplasmic HuR in familial adenomatous polyposis. Cancer Biol. Ther. 2008, 7, 424-427.
116. Fay, J.; Kelehan, P.; Lambkin, H.; Schwartz, S. Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer. J. Med. Virol. 2009, 81, 897-907.
117. Lopez de Silanes, I.; Fan, J.; Yang, X.; Zonderman, A.B.; Potapova, O.; Pizer, E.S.; Gorospe, M. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 2003, 22, 7146-7154.
118. Lopez de Silanes, I.; Fan, J.; Galban, C.J.; Spencer, R.G.; Becker, K.G.; Gorospe, M. Global analysis of HuR-regulated gene expression in colon cancer systems of reducing complexity. Gene Expr. 2004, 12, 49-59.
119. Milne, A.N.; Carvalho, R.; Morsink, F.M.; Musler, A.R.; de Leng, W.W.; Ristimaki, A.; Offerhaus, G.J. Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod. Pathol. 2006, 19, 564-572.
120. Young, L.E.; Sanduja, S.; Bemis-Standoli, K.; Pena, E.A.; Price, R.L.; Dixon, D.A. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 2009, 136, 1669-1679.
121. Cho, N.P.; Han, H.S.; Soh, Y.; Son, H.J. Overexpression of cyclooxygenase-2 correlates with cytoplasmic HuR expression in salivary mucoepidermoid carcinoma but not in pleomorphic adenoma. J. Oral. Pathol. Med. 2007, 36, 297-303.
122. Saunus, J.M.; French, J.D.; Edwards, S.L.; Beveridge, D.J.; Hatchell, E.C.; Wagner, S.A.; Stein, S.R.; Davidson, A.; Simpson, K.J.; Francis, G.D.; et al. Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR. Cancer Res. 2008, 68, 9469-9478.
123. Woo, H.H.; Yi, X.; Lamb, T.; Menzl, I.; Baker, T.; Shapiro, D.J.; Chambers, S.K. Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer. Mol. Cell Biol. 2011, 31, 215-225.
124. Guo, X.; Hartley, R.S. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells. Cancer Res. 2006, 66, 7948-7956.
125. Yuan, Z.; Sanders, A.J.; Ye, L.; Wang, Y.; Jiang, W.G. Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9. Oncol. Rep. 2011, 26, 237-245.
126. López de Silanes, I.; Gorospe, M.; Taniguchi, H.; Abdelmohsen, K.; Srikantan, S.; Alaminos, M.; Berdasco, M.; Urdinguio, R.G.; Fraga, M.F.; Jacinto, F.V.; et al. The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNA. Nucleic Acids Res. 2009, 37, 2658-2671.
127. Kakuguchi, W.; Kitamura, T.; Kuroshima, T.; Ishikawa, M.; Kitagawa, Y.; Totsuka, Y.; Shindoh, M.; Higashino, F. HuR knockdown changes the oncogenic potential of oral cancer cells. Mol. Cancer Res. 2010, 8, 520-528.
128. Linker, K.; Pautz A.; Fechir M.; Hubrich T.; Greeve J.; Kleinert H. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res. 2005, 33, 4813-4827.
129. Suzuki, E.; Tsutsumi, A.; Sugihara, M.; Mamura, M.; Goto, D.; Matsumoto, I.; Ito, S.; Ikeda, K.; Ochiai, N.; Sato Y.; et al. Expression of TNF-alpha.; tristetraprolin.; T-cell intracellular antigen-1 and Hu antigen R genes in synovium of patients with rheumatoid arthritis. Int. J. Mol. Med. 2006, 18, 273-278.
130. Nabors, L.B.; Gillespie, G.Y.; Harkins, L.; King, P.H. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine-and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res. 2001, 61, 2154-2161.
131. Ishimaru, D.; Ramalingam, S.; Sengupta, T.K.; Bandyopadhyay, S.; Dellis, S.; Tholanikunnel, B.G.; Fernandes, D.J.; Spicer, E.K. Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells. Mol. Cancer Res. 2009, 7, 1354-1366.
132. Pineda, D.M.; Rittenhouse, D.W.; Valley, C.C.; Cozzitorto, J.A.; Burkhart, R.A.; Leiby, B.; Winter, J.M.; Weber, M.C.; Londin, E.R.; Rigoutsos, I.; et al. HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells. Cancer Biol. Ther. 2012, 13, 946-955.
133. Giles, K.M.; Daly, J.M.; Beveridge, D.J.; Thomson, A.M.; Voon, D.C.; Furneaux, H.M.; Jazayeri, J.A.; Leedman, P.J. The 3'-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein. J. Biol. Chem. 2003, 278, 2937-2946.
134. Leandersson, K.; Riesbeck, K.; Andersson, T. Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucleic Acids Res. 2006, 34, 3988-3999.
135. Yoo, P.S.; Mulkeen, A.L.; Cha, C.H. Post-transcriptional regulation of vascular endothelial growth factor. Implications for tumor angiogenesis. World J. Gastroenterol. 2006, 12, 4937-4942.
136. Ido, K.; Nakagawa, T.; Sakuma, T.; Takeuchi, H.; Sato, K.; Kubota, T. Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human astrocytic tumors. Neuropathology 2008, 28, 604-611.
137. Sakuma, T.; Nakagawa, T.; Ido, K.; Takeuchi, H.; Sato, K.; Kubota, T. Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas. J. Neurooncol. 2008, 88, 143-155.
138. Niesporek, S.; Kristiansen, G.; Thoma, A.; Weichert, W.; Noske, A.; Buckendahl, A.C.; Jung, K.; Stephan, C.; Dietel, M.; Denkert, C. Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression. Int. J. Oncol. 2008, 32, 341-347.
139. Dixon, D.A.; Tolley, N.D.; King, P.H.; Nabors, L.B.; McIntyre, T.M.; Zimmerman, G.A.; Prescott, S.M. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Invest. 2001, 108, 1657-1665.
140. Erkinheimo, T.L.; Lassus, H.; Sivula, A.; Sengupta, S.; Furneaux, H.; Hla, T.; Haglund, C.; Butzow, R.; Ristimaki, A. Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res. 2003, 63, 7591-7594.
141. Yoo, P.S.; Sullivan, C.A.; Kiang, S.; Gao, W.; Uchio, E.M.; Chung, G.G.; Cha, C.H. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma. high expression of HuR predicts poor survival. Ann. Surg. Oncol. 2009, 16, 200-207.
142. Richards, N.G.; Rittenhouse, D.W.; Freydin, B.; Cozzitorto, J.A.; Grenda, D.; Rui, H.; Gonye, G.; Kennedy, E.P.; Yeo, C.J.; Brody, J.R.; et al. HuR status is a powerful marker for prognosis and response to
143. Kurosu, T.; Ohga, N.; Hida, Y.; Maishi, N.; Akiyama, K.; Kakuguchi, W.; Kuroshima, T.; Kondo, M.; Akino, T.; Totsuka, Y.; et al. HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium. Br. J. Cancer 2011, 104, 819-829.
144. Gubin, M.M.; Calaluce, R.; Davis, J.W.; Magee, J.D.; Strouse, C.S.; Shaw, D.P.; Ma, L.; Brown, A.; Hoffman, T.; Rold, T.L.; et al. Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis. Cell Cycle 2010, 9, 3337-3346.
145. Calaluce, R.; Gubin, M.M.; Davis, J.W.; Magee, J.D.; Chen, J.; Kuwano, Y.; Gorospe, M.; Atasoy, U. The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer. BMC Cancer 2010, 10, 126.
146. Ale-Agha, N.; Galban, S.; Sobieroy, C.; Abdelmohsen, K.; Gorospe, M.; Sies, H.; Klotz, L.O. HuR regulates gap junctional intercellular communication by controlling beta-catenin levels and adherens junction integrity. Hepatology 2009, 50, 1567-1576.
147. Lim, S.J.; Lee, S.H.; Joo, S.H.; Song, J.Y.; Choi, S.I. Cytoplasmic expression of HuR is related to cyclooxygenase-2 expression in colon cancer. Cancer Res. Treat. 2009, 41, 87-92.
148. Liang, P.I.; Li, W.M.; Wang, Y.H.; Wu, T.F.; Wu, W.R.; Liao, A.C.; Shen, K.H.; Wei, Y.C.; Hsing, C.H.; Shiue, Y.L.; et al. HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma. BMC Cancer 2012, 12, 611.
149. Heinonen, M.; Hemmes, A.; Salmenkivi, K.; Abdelmohsen, K.; Vilén, S.T.; Laakso, M.; Leidenius, M.; Salo, T.; Hautaniemi, S.; Gorospe, M.; et al. Role of RNA binding protein HuR in ductal carcinoma in situ of the breast. J. Pathol. 2011, 224, 529-539.
150. Lauriola, L.; Granone, P.; Ramella, S.; Lanza, P.; Ranelletti, F.O. Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma. Histol. Histopathol. 2012, 27, 617-626.
151. Tran, H.; Maurer, F.; Nagamine, Y. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol. Cell Biol. 2003, 23, 7177-7188.
152. Dong, R.; Lu, J.G.; Wang, Q.; He, X.L.; Chu, Y.K.; Ma, Q.J. Stabilization of Snail by HuR in the process of hydrogen peroxide induced cell migration. Biochem. Biophys. Res. Commun. 2007, 356, 318-321.
153. Lee, Y.R.; Noh, E.M.; Oh, H.J.; Hur, H.; Kim, J.M.; Han, J.H.; Hwang, J.K.; Park, B.H.; Park, J.W.; Youn, H.J.; et al. Dihydroavenanthramide D inhibits human breast cancer cell invasion through suppression of MMP-9 expression. Biochem. Biophys. Res. Commun. 2011, 405, 552-557.
154. Noh, E.M.; Lee, Y.R.; Hur, H.; Kim, J.S. Radix clematidis extract inhibits TPA-induced MMP-9 expression by suppressing NF-kappaB activation in MCF-7 human breast cancer cells. Mol. Med. Report. 2011, 4, 879-883.
155. Hsia, T.C.; Tu, C.Y.; Chen, Y.J.; Wei, Y.L.; Yu, M.C.; Hsu, S.C.; Tsai, S.L.; Chen, W.S.; Yeh, M.H.; Yen, C.J.; et al. Lapatinib-mediated COX-2 Expression Via EGFR/HuR interaction enhances the aggressiveness of triple-negative breast cancer cells. Mol. Pharmacol. 2013, 83, 857-869.
156. Filippova, N.; Yang, X.; Wang, Y.; Gillespie, G.Y.; Langford, C.; King, P.H.; Wheeler, C.; Nabors, L.B. The RNA-binding protein HuR promotes glioma growth and treatment resistance. Mol. Cancer Res. 2011, 9, 648-659.
157. Urano, N.; Fujiwara, Y.; Doki, Y.; Kim, S.J.; Miyoshi, Y.; Noguchi, S.; Miyata, H.; Takiguchi, S.; Yasuda, T.; Yano, M.; et al. Clinical significance of class III beta-tubulin expression and its predictive value for resistance to docetaxel-based chemotherapy in gastric cancer. Int. J. Oncol. 2006, 28, 375-381.
158. Lee, K.M.; Cao, D.; Itami, A.; Pour, P.M.; Hruban, R.H.; Maitra, A.; Ouellette, M.M. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Histopathology 2007, 51, 539-546.
159. Seve, P.; Isaac, S.; Tredan, O.; Souquet, P.J.; Pacheco, Y.; Perol, M.; Lafanechere, L.; Penet, A.; Peiller, E.L.; Dumontet, C. Expression of class III β-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy. Clin. Cancer Res. 2005, 11, 5481-5486.
160. Raspaglio, G.; de Maria, I.; Filippetti, F.; Martinelli, E.; Zannoni, G.F.; Prislei, S.; Ferrandina, G.; Shahabi, S.; Scambia, G.; Ferlini, C. HuR regulates beta-tubulin isotype expression in ovarian cancer. Cancer Res. 2010, 70, 5891-5900.
161. Liu, Z.M.; Tseng, J.T.; Hong, D.Y.; Huang, H.S. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. Biochem. J. 2011, 438, 349-358.
162. Serini, S.; Donato, V.; Piccioni, E.; Trombino, S.; Monego, G.; Toesca, A.; Innocenti, I.; Missori, M.; de Spirito, M.; Celleno, L.; et al. Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes. involvement of COX-2 and HuR. J. Nutr. Biochem. 2011, 22, 874-885.
163. Latorre, E.; Tebaldi, T.; Viero, G.; Sparta, A.M.; Quattrone, A.; Provenzani, A. Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells. Mol. Cancer 2012, doi:10.1186/1476-4598-11-13.
164. Griseri, P.; Bourcier, C.; Hieblot, C.; Essafi-Benkhadir, K.; Chamorey, E.; Touriol, C.; Pages, G. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. Hum. Mol. Genet. 2011, 20, 4556-4568.
165. Ronkainen, H.; Vaarala, M.H.; Hirvikoski, P.; Ristimaki, A. HuR expression is a marker of poor prognosis in renal cell carcinoma. Tumour. Biol. 2011, 32, 481-487.
166. Cha, J.D.; Li, S.; Cha, I.H. Association between expression of embryonic lethal abnormal vision-like protein HuR and cyclooxygenase-2 in oral squamous cell carcinoma. Head Neck 2011, 33, 627-637.
167. Zhu, Z.; Wang, B.; Bi, J.; Zhang, C.; Guo, Y.; Chu, H.; Liang, X.; Zhong, C.; Wang, J. Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer. Tumor. Biol. 2013, doi:10.1007/s13277-013-0774-3.
168. Yi, X.; Zhou, Y.; Zheng, W.; Chambers, S.K. HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer. Aust. N. Z. J. Obstet. Gynaecol. 2009, 49, 93-98.
169. Ortega, A.D.; Sala, S.; Espinosa, E.; Gonzalez-Baron, M.; Cuezva, J.M. HuR and the bioenergetic signature of breast cancer, a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence. Carcinogenesis 2008, 29, 2053-2061.
170. Yuan, Z.; Sanders, A.J.; Ye, L.; Wang, Y.; Jiang, W.G. Prognostic value of the human antigen R (HuR) in human breast cancer. high level predicts a favourable prognosis. Anticancer Res. 2011, 31, 303-310.
171. Lopez de Silanes, I.; Zhan, M.; Lal, A.; Yang, X.; Gorospe, M. Identification of a target RNA motif for RNA-binding protein HuR. Proc. Natl. Acad. Sci. USA 2004, 101, 2987-2992.
172. Lopez de Silanes, I.; Lal, A.; Gorospe, M. HuR post-transcriptional paths to malignancy. RNA Biol. 2005, 2, 11-13.
173. Lebedeva, S.; Jens, M.; Theil, K.; Schwanhäusser, B.; Selbach, M.; Landthaler, M.; Rajewsky, N. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol. Cell 2011, 43, 340-352.
174. Mukherjee, N.; Corcoran, D.L.; Nusbaum, J.D.; Reid, D.W.; Georgiev, S.; Hafner, M.; Ascano, M., Jr.; Tuschl, T.; Ohler, U.; Keene, J.D. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol. Cell 2011, 43, 327-339.
175. Kishore, S.; Jaskiewicz, L.; Burger, L.; Hausser, J.; Khorshid, M.; Zavolan, M. A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat. Methods 2011, 8, 559-564.
176. Akool el, S.; Kleinert, H.; Hamada, F.M.; Abdelwahab, M.H.; Forstermann, U.; Pfeilschifter, J.; Eberhardt, W. Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Mol. Cell Biol. 2003, 23, 4901-4916.